Have multiple conditions? Click here

New Clinical Trials for Colorectal Cancer

Despite many people suffering from issues related to colorectal cancer, they usually suffer in silence. Honestly, it can be a very personal and embarrassing subject to discuss. Patients are especially unwilling to come forth to participate in colorectal cancer clinical studies. Advocates for breast cancer research have made that an acceptable topic of conversation. Unfortunately the same has not yet happened for colorectal cancer.
 
If you or someone you know is suffering from this disease we encourage you to review the list of current colorectal cancer clinical trials. It may be difficult coming forward, but your participation may lead to knowledge that could help millions of people who suffer with this disease. Colorectal cancer clinical trials are strictly confidential and always at no cost to you.
 

What is Colorectal Cancer?

Colorectal cancer is also known as colon cancer or large bowel cancer. It occurs when cancer cells form in the colon, rectum or appendix. Colorectal cancer is the 4th most common cancer in the U.S. It is measured in stages and by the extent the cancer has spread. Factors considered during diagnosis include size and placement of the tumor, whether or not the lymph nodes are involved and whether or not the cancer has spread to distant areas of the body. Symptoms of colorectal cancer can include change in bowel movements, the presence of blood in stool, rectal obstruction, or abdominal pain.
 

Colorectal Cancer Treatments

Colorectal cancer treatments vary based on the diagnosis. If the cancer is confined to the colon it is usually treatable with surgery. If gone untreated it will spread to the lymph nodes. In these cases surgery and chemotherapy can still be effective. Stage IV, where the cancer has spread to distant sites, is usually not curable. Colorectal cancer is most often detected during a colonoscopy. Early diagnosis offers patients a much higher chance of successfully treating colorectal cancer.

Have multiple conditions? Click here

Showing 1-100 of 3423
There are 3423 Colorectal Cancer Clinical Trials
Name City State Zip
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Mobile AL 36608
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Mobile AL 36608
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery Mobile AL 36608
Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic FOLFOX6 Huntsville AL 35805
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies Huntsville AL 35801
PEAK: A Phase 2 Study of Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer Subjects With Wild-Type KRAS Tumors Birmingham AL
PAVES: Pegfilgrastim Anti-VEGF Evaluation Study Birmingham AL
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia Birmingham AL 35294
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies Birmingham AL 35216
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Fairbanks AK 99701
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Fairbanks AK 99701
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Anchorage AK 99508
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Tucson AZ 85723
Selenium for Prevention of Adenomatous Colorectal Polyps Tucson AZ 85724
Neurological Effects of Chemotherapy and Radiation Therapy in Patients With Colon Cancer Tucson AZ 85724
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer Tucson AZ 85712
Immune Response in Peripheral Blood of Patients With Colon Cancer Tucson AZ 85724
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma Tucson AZ 85724
Selenium for Prevention of Adenomatous Colorectal Polyps Scottsdale AZ 85259
Selenium for Prevention of Adenomatous Colorectal Polyps Scottsdale AZ 85258
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer Scottsdale AZ 85259
A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors Scottsdale AZ 85258
Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal Cancer Scottsdale AZ 85258
Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer Scottsdale AZ 85259
Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor Scottsdale AZ 85258
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Scottsdale AZ 85259
A Study in Second Line Metastatic Colorectal Cancer Scottsdale AZ 85259
Selenium for Prevention of Adenomatous Colorectal Polyps Phoenix AZ 85012
A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver Phoenix AZ 85013
Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments Phoenix AZ 85054
PAVES: Pegfilgrastim Anti-VEGF Evaluation Study Little Rock AR
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Little Rock AR 72205
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only Jonesboro AR 72401
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Ft. Smith AR 72903
A Rollover Protocol For Patients Who Received CP-675,206 In Other Protocols Fayetteville AR 72703
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck Fayetteville AR 72703
A Study in Second Line Metastatic Colorectal Cancer Fayetteville AR 72703
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Whittier CA 90602
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Walnut Creek CA 94596
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Walnut Creek CA 94596
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Walnut Creek CA 94598
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Walnut Creek CA 94596
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Walnut Creek CA 94596
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Vallejo CA 94589
A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver Vallejo CA 94589
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Vallejo CA 94589
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Vallejo CA 94589
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Vallejo CA 94589
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Vallejo CA 94589
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Vacaville CA 95688
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Vacaville CA 95688
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Vacaville CA 95688
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Turlock CA 95382
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Truckee CA 96161
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Stockton CA 95210
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Stockton CA 95210
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Stockton CA 95204
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Stockton CA 95204
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Stockton CA 95210
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Stockton CA 95204
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Stockton CA 95210
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Stockton CA 95204
Molecular Genetic and Pathological Studies of Anal Tumors Stanford CA 94305
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer Stanford CA 94305
Permission to Collect Blood Over Time for Research Stanford CA 94305
Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer Stanford CA 94305
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma Stanford CA 94305
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors Stanford CA 94305
Clinical and Pathological Studies of Upper Gastrointestinal Carcinoma Stanford CA 94305
B-Receptor Signaling in Cardiomyopathy Stanford CA 94305
Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors Stanford CA 94305
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies Stanford CA 94305
Early Removal of Urinary Catheters in Patients After Rectal Surgery: a Prospective Study Stanford CA 94305
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma St. Helena CA 94574
AVASTART - Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer South San Francisco CA
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy South San Francisco CA 94080
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery South San Francisco CA 94080
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer South Sacramento CA 95823
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery South Sacramento CA 95823
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy South Sacramento CA 95823
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery South Sacramento CA 95823
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Santa Rosa CA 95403
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Santa Rosa CA 95403
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Santa Rosa CA 95403
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Santa Rosa CA 95403
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma Santa Maria CA 93454
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Santa Clara CA 95051
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Santa Clara CA 95051
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Santa Clara CA 95051
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Santa Clara CA 95051
Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy Santa Clara CA 95051
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Santa Clara CA 95051
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Santa Clara CA 95051
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma Santa Barbara, CA 93105
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma Santa Barbara CA 93105
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer San Rafael CA 94903
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery San Rafael CA 94903
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy San Rafael CA 94903
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery San Rafael CA 94903
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery San Rafael CA 94903

Showing 1-100 of 3423
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register